Today: 8 June 2026
Browse Category

LSE:MPH 30 December 2025

Mereo BioPharma stock crashes 88% after Phase 3 setrusumab miss sinks brittle-bone hopes

Mereo BioPharma stock crashes 88% after Phase 3 setrusumab miss sinks brittle-bone hopes

Mereo BioPharma shares plunged 87.65% to $0.29 after late-stage trials of setrusumab failed to meet the main fracture-rate goal in osteogenesis imperfecta. Both Phase 3 studies missed the primary endpoint, though bone mineral density improved and no new safety issues appeared. Analysts cut ratings as the company moved to reduce spending. Trading volume reached about 241 million shares.
30 December 2025
··

Stock Market Today

  • Goldman Sachs Revises Forecast, Sees No Fed Rate Cuts in 2024
    June 8, 2026, 4:45 AM EDT. Goldman Sachs economists have revised their forecast, now expecting no interest rate cuts from the Federal Reserve in 2024. The change is driven by a stronger-than-expected labor market, which reduces the likelihood of the Fed easing policy this year. This signals continued monetary tightening amid persistent economic resilience, affecting market expectations for borrowing costs and investment decisions.

Latest articles

SpaceX Sets IPO at $135, Retail Buzz Ahead of SPCX Nasdaq Debut

SpaceX Sets IPO at $135, Retail Buzz Ahead of SPCX Nasdaq Debut

8 June 2026
SpaceX’s $75 billion IPO launches June 12 at $135 a share, with retail demand already double the shares on offer and 30% of the deal earmarked for individuals, but 2025 losses of $4.94 billion and a $1.75 trillion target valuation raise questions about post-IPO pricing as index entry and profitability remain uncertain.
Eli Lilly Set for Key Monday After New Weight-Loss Drug Data

Eli Lilly Set for Key Monday After New Weight-Loss Drug Data

8 June 2026
Eli Lilly closed at $1,131.42, up 0.55%, after releasing late-stage data showing its obesity drug retatrutide led to 28.3% weight loss over 80 weeks and reduced sleep apnea and knee pain, fueling hopes its obesity pipeline could expand beyond weight loss as rivals Boehringer Ingelheim and Zealand Pharma unveiled competing data, setting up a key test for Lilly’s trillion-dollar valuation as trading resumes.
SK Hynix Slips Even After Nvidia Deal as Korean AI Shares Slide

SK Hynix Slips Even After Nvidia Deal as Korean AI Shares Slide

8 June 2026
SK Hynix plunged 7.68% to 1,911,000 won despite sealing a multi-year Nvidia memory deal, as fears of a U.S. rate hike and a tech stock rout triggered circuit breakers and an 8.3% KOSPI crash, overshadowing strong AI demand and ongoing HBM supply constraints.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 08.06.2026

8 June 2026
LIVEMarkets rolling coverageStarted: June 8, 2026, 4:00 AM EDTUpdated: June 8, 2026, 4:45 AM EDT Goldman Sachs Revises Forecast, Sees No Fed Rate Cuts in 2024 June 8, 2026, 4:45 AM EDT. Goldman Sachs economists have revised their forecast, now expecting no interest rate cuts from the Federal Reserve in 2024. The change is driven by a stronger-than-expected labor market, which reduces the likelihood of the Fed easing policy this year. This signals continued monetary tightening amid persistent economic resilience, affecting market expectations for borrowing costs and investment decisions. Goldman Sachs No Longer Expects Fed Interest-Rate Cut This Year Oil
Go toTop